Skip to main content
. Author manuscript; available in PMC: 2014 Mar 24.
Published in final edited form as: J Clin Exp Ophthalmol. 2013 Nov 25;4(6):307. doi: 10.4172/2155-9570.1000307

Figure 1.

Figure 1

Incidence of anti-retinal autoantibodies in 3 groups of patients: CAR group - patients with symptoms of cancer associated retinopathy, Cancer group - patients with gynecological cancers without visual problems, Control group - healthy subjects. The presence of autoantibodies against human retinal proteins was investigated in the following gynecological cancers: endometrial, cervical, ovarian, and fallopian tube. The graph represents percent of seropositive patients within each group compared to controls.